The impact of clinical pharmacist in a cardiac-surgery intensive care unit

Saudi Medical Journal

Volumn 29, Issue 2, 2008, Pages 277-281

  Al Jazairi, Abdulrazaq S ^a   Al Agil, Amal A ^a   Asiri, Yousif A ^b   Al Kholi, Tariq A ^b   Akhras, Nathem S ^a   Horanieh, Bashar K ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PHARMACY; DRUG DOSE REGIMEN; DRUG INDICATION; FEMALE; HEART SURGERY; HOSPITAL PHARMACY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PHARMACIST; PRESCRIPTION; PROSPECTIVE STUDY; SAUDI ARABIA; TERTIARY HEALTH CARE;

CORONARY CARE UNITS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY; FEMALE; HUMANS; MALE; PATIENT CARE TEAM; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PILOT PROJECTS; PROSPECTIVE STUDIES; SAUDI ARABIA;

EID: 40749162385     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Johnson ST, Brown GC, Shea KM. Reengineering a pharmacist intervention program. Am J Health-Syst Pharm 2002; 59: 916-917.
2. Dobie RL, Rascati KL. Documenting the value of pharmacist interventions. Am Pharm 1994; NS34: 50-54.
3. Pickard AS, Johnson JA, Farris KB. The impact of pharmacist interventions on health-related quality of life. Ann Pharmacother 1999; 33: 167-1172.
4. Mitra Montazeri, Deboreah J Cook. Impact of a clinical pharmacist in a multidisciplinary intensive care unit. Crit Care Med 1994; 22: 1044-1048.
5. Kucukarslan SN, Peters M, Mlynarek M. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003; 163: 2014-2018.
6. Miyagawa CI, Rivera JO. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. Am J Hosp Pharm 1986; 43: 3008-3012.
7. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 1999; 159: 2306-2309.
8. Gattis, WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: Results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999; 159: 1939-1945.
9. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: The IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans affairs Medical Centers. Pharmacotherapy 2000; 20: 1508-1516.
10. Leape LL, Cullen DJ, Clapp MD, Burdick E, Demonaco HJ, Erickson JI. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 281: 267-270.
11. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm 2002; 59: 2089-2092.
12. Brock KA, Doucette WR. Collaborative working relationships between pharmacists and physicians: An exploratory study. Am Pharm Assoc 2004; 44: 358-365.
13. Kollef MH. Optimizing antibiotic therapy in the intensive care unit setting. Critical Care 2001; 5: 189-195.
14. Schumock GT. Butler MG. Meek PD. Vermeulen LC. Arondekar BV. Bauman JL. 2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003; 23: 113-132.
15. Zaidi ST. Hassan Y. Postma MJ. Ng SH. Impact of pharmacist recommendations on the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci 2003; 25: 299-302.
16. Kane SL, Weber RJ, Dasta JF. The impact of clinical pharmacists on enhancing patient outcomes. Intensive Care Med 2003; 29: 691-698.
17. Rudis MI, Brandl KM. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med 2000; 28: 3770-3771.
18. Kaboli PJ, Hoth AB, McClimon BJ, and Schniper JL. Clinical pharmacists and inpatient medical care. Arch Intern Med 2006; 166: 955-964.
19. Papadopoulos J, Rebuck JA, Lober C, Pass SE, Seidl EC, Shah RA. The critical care pharmacist: An essential intensive care practitioner. Pharmacotherapy 2002; 22: 1494-1498.
20. Kopp BJ, Mrsan M, Erstad BL, and Duby JJ. Cost implications of and potential adverse events prevented by interventions of critical care pharmacist. Am J Health Syst Pharm 2007; 64: 2483-2487.